Publication: Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
Loading...
Identifiers
Date
2019-10-16
Authors
Barbarroja, Nuria
Arias-de la Rosa, Ivan
Lopez-Medina, Clementina
Camacho-Sanchez, Maria Del Rosario
Gomez-Garcia, Ignacio
Velez Garcia-Nieto, Antonio
Escudero-Contreras, Alejandro
Lopez-Pedrera, Chary
Lopez-Montilla, Maria Dolores
Collantes-Estevez, Eduardo
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications
Abstract
Cardiovascular disease (CVD) is the main cause of mortality in patients with psoriatic disease. Traditional cardiovascular (CV) risk factors, such as arterial hypertension (HTA), type 2 diabetes (T2D), and dyslipidaemia are more prevalent in these patients compared with the general population.1 Besides, the chronic inflammatory state induced by psoriatic disease contributes to subclinical atherosclerosis, making it possible to consider psoriatic disease as an independent CV risk factor.2 In fact, accelerated atherosclerosis has been associated with both psoriasis and psoriatic arthritis (PsA), progression of which is responsible for the majority of CVD mortality in these patients
Description
MeSH Terms
Psoriasis
Risk factors
Hypertension
Inflammation
Atherosclerosis
Dyslipidemias
Risk factors
Hypertension
Inflammation
Atherosclerosis
Dyslipidemias
DeCS Terms
Aterosclerosis
Dislipidemias
Factores de fiesgo
Hipertensión
Inflamación
Dislipidemias
Factores de fiesgo
Hipertensión
Inflamación
CIE Terms
Keywords
Arthritis, psoriatic, Cardiovascular diseases, Diabetes mellitus, type 2, Technology assessment, biomedical
Citation
Barbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, et al. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742